Sedation Strategies from the Emergency Interface to ICU Liberation: A Systematic Review of Agent Selection and Weaning Outcomes

Authors

  • Sultan Saad Alotaibi Respiratory Therapist, Respiratory Care Services, Intensive Care Unit, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia. Author
  • Reem Yahya Alhiqwi Respiratory Therapist, Respiratory Care Services, Intensive Care Unit, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia. Author
  • Maha Bandar Alotaibi Respiratory Therapist, Respiratory Care Services, Intensive Care Unit, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia. Author
  • Rana Fawaz Almutairi Respiratory Therapist, Respiratory Care Services, Intensive Care Unit, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia. Author
  • Nedaa Ali Aldowasari Medical Laboratory Technologist, Medical Laboratories, King Khalid University Hospital, Riyadh, Saudi Arabia. Author
  • Abdulrahman Ali Hamithi Laboratory Specialist, King Khalid University Hospital, Riyadh, Saudi Arabia. Author
  • Mohammed Faisal Alajmi ED Consultant, Emergency Department, First Health Cluster, IAFH, Riyadh, Saudi Arabia. Author
  • Asma Noureddine Chargui Emergency Registrar, Emergency Department, First Health Cluster, IAFH, Riyadh, Saudi Arabia Author

DOI:

https://doi.org/10.65759/x3arwh48

Keywords:

Sedation, dexmedetomidine, propofol, benzodiazepines, mechanical ventilation

Abstract

Background: Sedation for mechanically ventilated adults begins at the emergency interface and continues through intensive care liberation, where depth, drug class, analgesia, delirium prevention, and awakening trials interact. Objective: This systematic review evaluated how sedative selection and sedation-minimization strategies influence delirium, ventilator liberation, intensive care duration, mortality, and adverse events. Methods: PubMed/MEDLINE, Scopus, Web of Science Core Collection, Cochrane CENTRAL, and Cochrane Database of Systematic Reviews were searched for adult studies of invasive mechanical ventilation, emergency department or intensive care sedation, sedative agent comparison, sedation interruption, no-sedation protocols, and liberation outcomes. Original randomized trials and prospective cohorts were prioritized for the results synthesis. Results: Ten original studies were included in the qualitative results synthesis. Benzodiazepine-based sedation was consistently linked with less favorable delirium or extubation profiles than dexmedetomidine-based strategies in several randomized trials. Dexmedetomidine improved arousability and communication, reduced delirium in comparisons with benzodiazepines, and shortened extubation time in selected populations, although large trials showed similar mortality and ventilator-free outcomes compared with usual care or propofol. Daily awakening, paired awakening-breathing trials, no-sedation protocols, and targeted emergency department sedation reduced unnecessary deep sedation and aligned sedation with liberation readiness. Conclusion: The evidence favors early light sedation, avoidance of benzodiazepine accumulation, protocolized awakening, and agent selection matched to delirium and liberation goals.

References

1. Devlin JW, Skrobik Y, Gelinas C, Needham DM, Slooter AJC, Pandharipande PP, et al. Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU. Crit Care Med. 2018;46(9):e825-e873. doi:10.1097/CCM.0000000000003299.

2. Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014;370(5):444-454. doi:10.1056/NEJMra1208705.

3. Lewis K, Alshamsi F, Carayannopoulos KL, Granholm A, Piticaru J, Al Duhailib Z, et al. Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive Care Med. 2022;48(7):811-840. doi:10.1007/s00134-022-06712-2.

4. Chen K, Lu Z, Xin YC, Cai Y, Chen Y, Pan SM. Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev. 2015;(1):CD010269. doi:10.1002/14651858.CD010269.pub2.

5. Burry L, Rose L, McCullagh IJ, Fergusson DA, Ferguson ND, Mehta S. Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation. Cochrane Database Syst Rev. 2014;(7):CD009176. doi:10.1002/14651858.CD009176.pub2.

6. Ouellette DR, Patel S, Girard TD, Morris PE, Schmidt GA, Truwit JD, et al. Liberation From Mechanical Ventilation in Critically Ill Adults: An Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline. Chest. 2017;151(1):166-180. doi:10.1016/j.chest.2016.10.036.

7. Fraser GL, Devlin JW, Worby CP, Alhazzani W, Barr J, Dasta JF, et al. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med. 2013;41(9 Suppl 1):S30-S38. doi:10.1097/CCM.0b013e3182a16898.

8. Stephens RJ, Dettmer MR, Roberts BW, Ablordeppey E, Fowler SA, Kollef MH, et al. Practice patterns and outcomes associated with early sedation depth in mechanically ventilated patients: a systematic review and meta-analysis. Crit Care Med. 2018;46(3):471-479. doi:10.1097/CCM.0000000000002885.

9. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000;342(20):1471-1477. doi:10.1056/NEJM200005183422002.

10. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR 3rd, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644-2653. doi:10.1001/jama.298.22.2644.

11. Girard TD, Kress JP, Fuchs BD, Thomason JWW, Schweickert WD, Pun BT, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care: the Awakening and Breathing Controlled trial. Lancet. 2008;371(9607):126-134. doi:10.1016/S0140-6736(08)60105-1.

12. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489-499. doi:10.1001/jama.2009.56.

13. Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomized trial. Lancet. 2010;375(9713):475-480. doi:10.1016/S0140-6736(09)62072-9.

14. Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, et al. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012;307(11):1151-1160. doi:10.1001/jama.2012.304.

15. Reade MC, Eastwood GM, Bellomo R, Bailey M, Bersten A, Cheung B, et al. Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial. JAMA. 2016;315(14):1460-1468. doi:10.1001/jama.2016.2707.

16. Fuller BM, Roberts BW, Mohr NM, Knight WA, Adeoye O, Pappal RD, et al. The ED-SED Study: a multicenter, prospective cohort study of practice patterns and clinical outcomes associated with emergency department sedation for mechanically ventilated patients. Crit Care Med. 2019;47(11):1539-1548. doi:10.1097/CCM.0000000000003928.

17. Shehabi Y, Howe BD, Bellomo R, Arabi YM, Bailey M, Bass FE, et al. Early sedation with dexmedetomidine in critically ill patients. N Engl J Med. 2019;380(26):2506-2517. doi:10.1056/NEJMoa1904710.

18. Hughes CG, Mailloux PT, Devlin JW, Swan JT, Sanders RD, Anzueto A, et al. Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis. N Engl J Med. 2021;384(15):1424-1436. doi:10.1056/NEJMoa2024922.

Downloads

Published

2026-06-29

Issue

Vol. 2 No. 3 (2025): Journal of Tazeez for Public Health

Section

Articles